|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02637 HAIXI PHARMA
Nominal 
192.400 +2.700 (+1.423%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | |
| Turnover | 311,619 | 3.847% | 300,075 |
| Cost of Sales | (56,462) | 39.018% | (40,615) |
| Gross Profit | 255,157 | -1.659% | 259,460 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | |
| Change in FV & Impairment on Others | 1,495 | -71.027% | 5,161 | |
| Profit / (Loss) on Disposal | 9 | -- | -- | |
| Other Non-operating Items | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | |
| Profit / (Loss) before Taxation | 84,300 | -31.402% | 122,890 | |
| Taxation | (3,252) | -78.444% | (15,084) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | |
| Others | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 81,049 | -24.820% | 107,806 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 11,759 | 321.039% | 2,793 |
| Depreciation & Amortisation | 10,666 | 332.020% | 2,469 |
| Directors' Emoluments | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | |
| Auditor's Opinion Status | N/A | -- | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | |
| EPS (cts) | 103.000 | -35.625% | 160.000 |
| DPS (cts) | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- |
| NBV per share ($) | 21.208 | -- | -- |
| Remarks: | Real time quote last updated: 11/09/2026 14:33 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 81,049 |
| %Change | -24.820% |
| EPS / (LPS) | RMB 1.030 |
| NBV Per Share (¥) | RMB 21.208 |